SGX393
SGX393 (SGX70393) is a Bcr-Abl kinase inhibitor. SGX393 binds to the active conformation of the kinase domains of both wild-type and T315I mutant Bcr-Abl, thereby inhibiting kinase activity. SGX393 exhibits antiproliferative effects in cells expressing wild-type or T315I mutant Bcr-Abl, and suppresses T315I-driven tumor growth. SGX393 can be used for the research of chronic myeloid leukemia.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 1030610-86-6
- Formule: C21H22N6O
- Masse moléculaire:374.45
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
SGX393 potently inhibits the proliferation of Ba/F3 cells expressing WT Bcr-Abl (IC50 = 12 nM) and Bcr-AblT315I (IC50 = 7.3 nM), while being inactive against parental Ba/F3 cells[1].
SGX393 inhibits Bcr-Abl kinase activity in primary CML cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 1030610-86-6
-
Masse moléculaire 374.45
-
Formule C21H22N6O
-
SMILES
O=C(C=1C=C(C=CC1N)C2=CN=C3NC=C(C3=C2)C4=CC=NN4CC)N(C)C
-
Synonyms
SGX70393
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)